INIS
colombia
100%
patients
62%
comparative evaluations
55%
risks
54%
guidelines
54%
hospitals
50%
prediction
45%
cost
45%
evaluation
45%
colchicine
45%
Pharmacology, Toxicology and Pharmaceutical Science
Rosuvastatin
56%
Dyslipidemia
54%
Diseases
54%
Emtricitabine
45%
Colchicine
45%
Tenofovir
45%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
45%
Brugada Syndrome
45%
Heart Ventricle Fibrillation
45%
Low Density Lipoprotein Cholesterol
45%
Keyphrases
Chronic Disease
45%
Evidence-based Decision Making
45%
Guideline Evaluation
45%
Healthcare in Developing Countries
45%
Text Data
45%
Medical Control
45%
Medical Practice
45%
Medical Guidelines
45%
Narrative Text
45%
Strategies to Overcome
45%